Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Dec'16
Net Sales
316.61
171.55
187.80
195.89
213.31
236.71
189.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
316.61
171.55
187.80
195.89
213.31
236.71
189.48
Raw Material Cost
95.58
42.18
45.47
60.90
61.92
57.19
55.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.04
1.64
2.58
2.69
2.74
1.14
0.00
Selling and Distribution Expenses
93.55
75.32
78.60
76.37
60.51
71.12
51.46
Other Expenses
2.99
4.96
2.82
3.41
4.17
3.15
3.03
Total Expenditure (Excl Depreciation)
223.05
168.78
154.85
174.08
166.84
160.91
137.02
Operating Profit (PBDIT) excl Other Income
93.6
2.8000000000000003
33
21.8
46.5
75.8
52.5
Other Income
-7.98
0.52
-7.70
2.87
0.16
0.09
1.83
Operating Profit (PBDIT)
98.84
8.09
30.02
29.34
50.30
79.64
55.87
Interest
4.04
1.64
2.58
2.69
2.74
1.14
0.00
Exceptional Items
-20.10
-6.20
0.00
0.00
-9.85
-1.81
-0.86
Gross Profit (PBDT)
221.03
129.37
142.34
135.00
151.40
179.52
134.18
Depreciation
13.27
4.81
4.77
4.65
3.67
3.75
1.59
Profit Before Tax
61.43
-4.55
22.68
22.00
34.04
72.94
53.43
Tax
25.79
4.08
10.69
7.68
2.13
21.00
-28.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
35.64
-8.63
11.99
14.31
31.90
51.94
81.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
35.64
-8.63
11.99
14.31
31.90
51.94
81.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.64
-8.63
11.99
14.31
31.90
51.94
81.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
233.56
176.45
186.01
179.17
160.76
179.14
151.23
Earnings per share (EPS)
2.73
-0.66
0.87
1.01
2.09
3.27
4.96
Diluted Earnings per share
2.73
-0.66
0.87
1.01
2.09
3.27
4.96
Operating Profit Margin (Excl OI)
29.55%
1.61%
17.55%
11.14%
21.78%
32.02%
27.68%
Gross Profit Margin
23.59%
0.15%
14.61%
13.6%
17.68%
32.4%
29.03%
PAT Margin
11.26%
-5.03%
6.38%
7.31%
14.96%
21.94%
42.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2022 is 84.61% vs -8.68% in Dec 2021
Consolidate Net Profit
YoY Growth in year ended Dec 2022 is 513.95% vs -171.67% in Dec 2021
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2022 is 1,305.26% vs -79.84% in Dec 2021
Interest
YoY Growth in year ended Dec 2022 is 150.00% vs -38.46% in Dec 2021
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2022 has improved from Dec 2021
Compare Annual Results Of Eagle Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
316.61
0.00
316.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
316.61
0.00
316.61
Raw Material Cost
95.58
0.00
95.58
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.04
0.00
4.04
Selling and Distribution Expenses
93.55
34.45
59.10
171.55%
Other Expenses
2.99
7.71
-4.72
-61.22%
Total Expenditure (Excl Depreciation)
223.05
111.56
111.49
99.94%
Operating Profit (PBDIT) excl Other Income
93.56
-111.56
205.12
183.87%
Other Income
-7.98
17.30
-25.28
-146.13%
Operating Profit (PBDIT)
98.84
-94.26
193.10
204.86%
Interest
4.04
0.00
4.04
Exceptional Items
-20.10
0.00
-20.10
Gross Profit (PBDT)
221.03
0.00
221.03
Depreciation
13.27
0.00
13.27
Profit Before Tax
61.43
-94.26
155.69
165.17%
Tax
25.79
0.00
25.79
Provisions and contingencies
0.00
0
0.00
Profit After Tax
35.64
-94.26
129.90
137.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
35.64
-94.26
129.90
137.81%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.64
-94.26
129.90
137.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
233.56
223.94
9.62
4.30%
Earnings per share (EPS)
2.73
-1.68
4.41
262.50%
Diluted Earnings per share
2.73
-1.68
4.41
262.50%
Operating Profit Margin (Excl OI)
29.55%
0.00%
0.00
29.55%
Gross Profit Margin
23.59%
0.00%
0.00
23.59%
PAT Margin
11.26%
0.00%
0.00
11.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 31.66 Million
in Dec 2022Figures in Million
YoY Growth in year ended Dec 2022 is 84.61% vs -8.68% in Dec 2021
Annual - Consolidate Net Profit
Consolidate Net Profit 3.56 Million
in Dec 2022Figures in Million
YoY Growth in year ended Dec 2022 is 513.95% vs -171.67% in Dec 2021
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.68 Million
in Dec 2022Figures in Million
YoY Growth in year ended Dec 2022 is 1,305.26% vs -79.84% in Dec 2021
Annual - Interest
Interest 0.40 Million
in Dec 2022Figures in Million
YoY Growth in year ended Dec 2022 is 150.00% vs -38.46% in Dec 2021
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.55%
in Dec 2022Figures in %
YoY Growth in year ended Dec 2022 has improved from Dec 2021
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
